News

Published on 10 May 2024 on Insider Monkey via Yahoo Finance

bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript

Article preview image

bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript May 9, 2024

bluebird bio, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here).

Operator: Thank you for standing by, and welcome to the bluebird bio First Quarter 202 Results Call. [Operator Instructions] Finally, you are reminded that this conference is being recorded.

Read the rest of the article
NASDAQ.BLUE price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
bluebird bio, Inc. (BLUE): Is This Gene Therapy Stock a Good Buy Right Now?

We recently compiled a list of the 10 Best Gene Therapy Stocks to Buy Right Now. In this article,...

Insider Monkey · via Yahoo Finance 29 Dec 2024
Traders Buy High Volume of Call Options on bluebird bio (NASDAQ:BLUE)

Traders purchased 27,165 call options on the company. This is an increase of approximately 1,278%...

ETF DAILY NEWS 6 Dec 2024
Why Verint Systems Shares Are Trading Higher By Around 23%; Here Are 20 Stocks...

Shares of Verint Systems Inc. VRNT rose sharply in today's pre-market trading after the company r...

Benzinga 5 Dec 2024
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.69% By...

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.69%

Investing.com 4 Dec 2024
bluebird bio Inc (BLUE) Q3 2024 Earnings Call Highlights: Navigating Revenue...

Total Revenue: $10.6 million in Q3, down from $16.1 million in Q2. Projected Q4 Revenue: At least...

GuruFocus.com · via Yahoo Finance 14 Nov 2024
bluebird bio (BLUE): Promising Gene Editing Stock with FDA-Approved Therapies

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge...

Insider Monkey · via Yahoo Finance 31 Oct 2024
bluebird (BLUE) Tops on Q1 Sales, Zynteglo Progresses Well

bluebird bio BLUE registered revenues of $18.6 million in the first quarter, up from $2.4 million...

Zacks via Yahoo Finance 10 May 2024
bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript

bluebird bio, Inc. (NASDAQ:BLUE) Q1 2024 Earnings Call Transcript May 9, 2024 bluebird bio, Inc. ...

Insider Monkey via Yahoo Finance 10 May 2024
Earnings call: Bluebird bio reports Q1 2024 results, anticipates growth By Investing.com

Bluebird bio Inc. (BLUE) has announced its first-quarter 2024 financial results, highlighting the...

Investing.com 10 May 2024
bluebird bio reports first commercial gene therapy use By Investing.com

This development marks a major step in making the treatment accessible to patients with a history...

Investing.com 7 May 2024

Copyright Statfolio @ 2025

Social Accounts